Search
for
Sort by
Research 691–720 of 1000+
- EPH225 Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity Among Adults in Taiwan
- Line‐field confocal optical coherence tomography in alopecia areata and histopathological correlation
- Comparison of Novel Hematological Biomarkers in Alopecia Areata and Other Not-Cicatricial Alopecia: A Retrospective Study
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Advances in the mechanism and new therapies of alopecia areata
- The Association between Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Psychological Characteristics of Alopecia Areata and Androgenetic Alopecia in Women
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Guidelines for the management of alopecia areata
- Epidemiology and burden of alopecia areata: a systematic review
- Alopecia Areata: An Updated Review for 2023
- Alopecia Areata: An Evidence-Based Treatment Update
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Alopecia Areata
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- Alopecia Areata: An Update on Treatment Options for Children
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata
- Study on Serum Vitamin D in Alopecia Areata Patients
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Estimation of health utility values for alopecia areata